The Global Chemotherapy At Home Services Market Size is predicted witness a 5.49% CAGR during the forecast period for 2023-2031.
Chemotherapy is a class of cancer treatment that entails giving patients one or more anti-cancer chemicals, also referred to as "chemotherapeutic agents," as part of a predetermined course of care. One of the main factors pushing the expansion of the global market for chemotherapy devices is the increased prevalence of various malignancies across the globe.
Multiple cancer types, including sarcoma, lung cancer, lymphoma, myeloma, and breast cancer, are becoming more common. This is projected to be a major growth driver for the global market for chemotherapy at-home services. The main factors fueling demand for chemotherapy at-home services globally are the rise in rates of various cancer kinds and increased preferences for at-home medical care.
The market demand is anticipated to be impacted by expanding technical developments, an increase in the elderly population, and significant investments in the healthcare sector. Increased government initiatives for developing the COVID-19 vaccine, growing consumer demand for advanced point-of-care diagnostics and home healthcare products, and growing acceptance of telehealth and telemedicine services have contributed to the industry's expansion.
Additionally, strategic alliances and collaborations are crucial for propelling the global market for chemotherapy at-home services. However, the global market for chemotherapy at-home services may need more competent labor, numerous product recalls, and inconsistent usage instructions.
Recent Development
- In February 2020-The Penn Center for Cancer Care Innovation at the Abramson Cancer Center of the University of Pennsylvania introduced the Cancer Care at Home initiative. It sought to increase the availability of oncology therapies for patients in their homes.
Competitive Landscape
Some of the Chemotherapy At Home Services market players are:
- Portea Medical Pvt. Ltd
- HealthCare atHOM
- Ubiqare Health Pvt. Ltd.
- Vitalis Health
- Home Care Pty Ltd
- Medibank Private Limited
- Advocate Medical Group
- View Health Pty Ltd
- CVS Health Corporation
Market Segmentation:
The chemotherapy at-home services market is segmented on the product, route of administration and cancer type. The market is segregated into chemotherapy drugs and infusion pumps based on product. Based on the route of administration, the chemotherapy at-home services market is segmented into oral and intravenous. Based on cancer type, the chemotherapy at-home services market is segmented into breast, blood, ovarian, colorectal, and others.
Based On Cancer Type, The Breast Cancer Segment Is A Major Contributor To The Chemotherapy At-Home Services Market
The market's leading segment is breast cancer. Breast cancer is one of the most prevailing diseases in the world, and R&D projects are being undertaken to address the issue. All those experiencing the same problems have benefited from the current market trend. In many regions, there is a high demand for the breast cancer market's screening, treatment, and services.
The Chemotherapy Drugs Segment Witnessed Growth At A Rapid Rate
Chemotherapy drugs grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. Chemotherapy's drugs most recent innovation is the infusion of cancer-fighting medications (tailored nanoparticles) into contaminated areas without harming healthy cells. This method has been proven to eradicate malignant cells while protecting good tissue. Doctors employ photon lasers to analyze the duration and distribution of these medications' ability to kill cancer cells. Clinical trials and research have proven effective in treating patients with early-stage cancer, and they are anticipated to boost the chemotherapy at-home services market significantly.
The North American Chemotherapy At-Home Services Market Holds A Significant Regional Revenue Share
The North American chemotherapy at-home services market is expected to register the highest market share in revenue shortly due to an increase in patients, an aging population, and cancer cases. Another important element is the region's increased government investment and well-established research infrastructure, developing new technologies, adopting new gadgets to reduce population suffering, and emerging new technologies.
Additionally, due to alliances and acquisitions made by businesses in the region, the market for chemotherapy at-home services is anticipated to grow globally. In addition, Asia Pacific is projected to grow rapidly in the global Chemotherapy At Home Services market due to expanding government initiatives to enhance chemotherapeutic methods. The rising incidence of cancer, the developed healthcare system, and increased government spending are all significant drivers of market growth in those areas.
Chemotherapy At Home Services Market Report Scope:
|
Report Attribute |
Specifications |
|
Growth rate CAGR |
CAGR of 5.49% from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Product, Route Of Administration And Cancer Type |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Portea Medical Pvt. Ltd., HealthCare atHOME, Ubiqare Health Pvt. Ltd., Vitalis Health and Home Care Pty Ltd, Medibank Private Limited, Advocate Medical Group, View Health Pty Ltd, and CVS Health Corporation. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
